Class ITerminatedD-1292-2019
Drug recall · May 22, 2019
Titanium 4000 recall
Why: Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020
- Lots / codes
Expiration 12/29/2020
- Quantity
- unknown
- Company
- D.B.P. Distribution, Chatsworth, CA
- Distribution
- Nationwide.
- Initiated
- April 23, 2019 · Voluntary: Firm initiated
- Classified
- May 22, 2019
- Reported
- May 22, 2019
- Ended
- March 7, 2023
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.